Pages not connected to items
Jump to navigation
Jump to search
This page lists pages with no connected data item (in namespaces that support connected items). The list is sorted by descending page ID, so that newer pages are listed first.
Showing below up to 50 results in range #5,151 to #5,200.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Li Q, et al, N Engl J Med (2020) cited as Ref 4 in DOI: 10.3201/eid2605.200146 (Q11210)
- Imai N, et al, Imperial College London (2020) cited as Ref 3 in DOI: 10.3201/eid2605.200146 (Q11209)
- World Health Organization, et al, Geneva: the Organization (2020) cited as Ref 2 in DOI: 10.3201/eid2605.200146 (Q11208)
- Wuhan Municipal Health Commission, et al, Wuhan Municipal Health Commission (2020) cited as Ref 1 in DOI: 10.3201/eid2605.200146 (Q11207)
- Wu SM (10th author of DOI: 10.1007/s11886-020-01292-3) (Q11206)
- Nguyen PK (9th author of DOI: 10.1007/s11886-020-01292-3) (Q11205)
- Davis MM (8th author of DOI: 10.1007/s11886-020-01292-3) (Q11204)
- Maecker H (7th author of DOI: 10.1007/s11886-020-01292-3) (Q11203)
- Witteles RM (6th author of DOI: 10.1007/s11886-020-01292-3) (Q11202)
- Chang A (5th author of DOI: 10.1007/s11886-020-01292-3) (Q11201)
- Waliany S (4th author of DOI: 10.1007/s11886-020-01292-3) (Q11200)
- Cheng P (3rd author of DOI: 10.1007/s11886-020-01292-3) (Q11199)
- Rhee JW (2nd author of DOI: 10.1007/s11886-020-01292-3) (Q11198)
- Zhu H (1st author of DOI: 10.1007/s11886-020-01292-3) (Q11197)
- Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response (DOI: 10.1007/s11886-020-01292-3) (Q11196)
- References (from DOI: 10.1016/j.clim.2020.108427) (Q11195)
- Declaration of Competing Interest (from DOI: 10.1016/j.clim.2020.108427) (Q11194)
- Financial support (from DOI: 10.1016/j.clim.2020.108427) (Q11193)
- Section 6: Conclusions (from DOI: 10.1016/j.clim.2020.108427) (Q11192)
- Section 5: Potential explanation for the difference between children and adults in COVID-19 (from DOI: 10.1016/j.clim.2020.108427) (Q11191)
- Section 4: Host response to SARS-CoV-2 (from DOI: 10.1016/j.clim.2020.108427) (Q11190)
- Section 3: Mechanism of SARS-CoV-2 invasion into host cells (from DOI: 10.1016/j.clim.2020.108427) (Q11189)
- Section 2: Epidemiological data of COVID-19 (from DOI: 10.1016/j.clim.2020.108427) (Q11188)
- Section 1: Introduction (from DOI: 10.1016/j.clim.2020.108427) (Q11187)
- Koutsogiannaki S (3rd author of DOI 10.1016/j.clim.2020.108427) (Q11186)
- Fujiogi M (2nd author of DOI 10.1016/j.clim.2020.108427) (Q11185)
- Yuki K (1st author of DOI 10.1016/j.clim.2020.108427) (Q11184)
- COVID-19 pathophysiology: A review (DOI: 10.1016/j.clim.2020.108427) (Q11183)
- References (from DOI: 10.1084/jem.20200653)
- Section 4: COVID-19 treatment by IFN-lambda: Pros and cons (from DOI: 10.1084/jem.20200653)
- Section 3: IFN-lambda as an antiviral drug (from DOI: 10.1084/jem.20200653)
- Section 2: IFNs as natural broad-spectrum antivirals (from DOI: 10.1084/jem.20200653)
- Section 1: Introduction (from DOI: 10.1084/jem.20200653)
- References (from DOI: 10.1084/jem.20200653) (Q11182)
- Section 4: COVID-19 treatment by IFN-lambda: Pros and cons (from DOI: 10.1084/jem.20200653) (Q11181)
- Section 3: IFN-lambda as an antiviral drug (from DOI: 10.1084/jem.20200653) (Q11180)
- Section 2: IFNs as natural broad-spectrum antivirals (from DOI: 10.1084/jem.20200653) (Q11179)
- Section 1: Introduction (from DOI: 10.1084/jem.20200653) (Q11178)
- Zhang L (6th author of DOI: 10.14218/ERHM.2020.00023) (Q11177)
- Gao N (5th author of DOI: 10.14218/ERHM.2020.00023) (Q11176)
- Wang H (4th author of DOI: 10.14218/ERHM.2020.00023) (Q11175)
- Hussain S (3rd author of DOI: 10.14218/ERHM.2020.00023) (Q11174)
- Xu J (2nd author of DOI: 10.14218/ERHM.2020.00023) (Q11173)
- Yuan X (1st author of DOI: 10.14218/ERHM.2020.00023) (Q11172)
- References (from DOI: 10.1016/j.adro.2020.04.015) (Q11171)
- Section 4: Discussion (from DOI: 10.1016/j.adro.2020.04.015) (Q11170)
- Section 3: Results (from DOI: 10.1016/j.adro.2020.04.015) (Q11169)
- Section 2: Methods (from DOI: 10.1016/j.adro.2020.04.015) (Q11168)
- Section 1: Introduction (from DOI: 10.1016/j.adro.2020.04.015) (Q11167)
- Reference (from DOI: 10.3201/eid2605.200146 ) (Q11166)